IP Library Granted Patent US 7,560,485
Granted Patent B2
US 7,560,485 · App. 11/242,136 · Granted Jul 14, 2009

Method for treating intermittent claudication comprising the administration of propionyl L-carnitine and a concomitant physical training

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,560,485
App. No.
11/242,136
Granted
Jul 14, 2009
Kind
B2
Abstract

The present invention discloses a method for treating a subject suffering from intermittent claudication (IC) wherein said subject takes an effective dose of propionyl L-carnitine or a pharmaceutically acceptable salt thereof and also engaging in a concomitant physical training program. The method is particular effective for patients with intermittent claudication at class II of the Leriche-Fontaine's classification. The method provides a relief from peripheral arterial disease symptoms, as shown by claudication-limited exercise tolerance, while also improving quality of life.

Claims (7)

1. A method for treating a subject suffering from intermittent claudication (IC) wherein said subject takes an effective dose of propionyl L-carnitine or a pharmaceutically acceptable salt thereof and also engages in a concomitant physical training program selected from the group consisting of: 3 times a day walking between about 1000 to 1500 m; 1-2 times a day walk for intervals 5-6 times over 80-100 m; 3 times daily 20-30 minutes a hill walk; walking a whole day; 0.5-2 hour daily walk; 2-8 km/day, v=2-4 km/h; walking program of 10 minutes/day; walking ½ mile 5 days/wk to the point of pain, then walking further; walks several times every day until point of pain or tightness; bicycle 10 km a day; exercise bike and/or stair climber; riding a stationary bicycle-about 5 min at a time, 1-2 times daily; supervised exercise training programs as administered in a rehabilitation facility; gymnastics 25× standing on toes home trainer; massages; hydrotherapy; 30 minutes total treadmill times 6-7×/wk; and swim every day.

2. The method according to claim 1 , wherein said salt of propionyl L-carnitine is selected from the group consisting of chloride, bromide, orotate, acid aspartate, acid citrate, magnesium citrate, acid phosphate, fumarate, acid fumarate, magnesium fumarate, lactate, maleate, acid maleate, mucate, acid oxalate, pamoate, acid pamoate, acid sulfate, glucose phosphate, tartrate, acid tartrate, magnesium tartrate, 2-amino ethansulfonate, magnesium 2-amino ethansulfonate, choline tartrate and trichloroacetate.

3. The method according to claim 1 , wherein said intermittent claudication is at class II of the Lenche-Fontaine's classification.

4. The method according to claim 1 , wherein said patient does not suffer from rest pain.

5. The method according to claim 1 , wherein said propionyl L-carnitine is in the form of a package suitable for oral treatment.

6. The method according to claim 1 , wherein said propionyl L-carnitine is given at a dose between about 1 g/day to about 4 g/day.

7. The method according to claim 1 , wherein said treatment lasts about 6 to 12 months.

Assignments (2)
CHANGE OF ADDRESS Recorded Oct 15, 2019
From: ALFASIGMA S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 050727/0652 →
MERGER Recorded Nov 14, 2017
From: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
To: ALFASIGMA S.P.A.
Reel/Frame 044760/0906 →